Antimicrobial resistance testing of Helicobacter pylori: A comparison of Etest and disk diffusion methods

Pathology

Volumn 29, Issue 4, 1997, Pages 411-414

  Midolo, Peter D ^a   Bell, Jan M ^b   Lambert, John R ^c   Turnidge, John D ^b   Lindsay Grayson, M ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c PENINSULA HEALTH   (Australia)

Author keywords

Antimicrobial resistance; Disk diffusion; Etest; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; COST; CROSS RESISTANCE; DIFFUSION; HELICOBACTER PYLORI; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION;

EID: 0030656297     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169415     Document Type: Article

References (16)

1. Glupczynski Y. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81.
2. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance - A predictor of failure to eradicate Helicobacter pylori by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2.
3. Bell GD, Powell K, Burridge SM, Pallecaross A, Jones PH, Gant PW et al. Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Ailment Pharmacol Ther 1992; 6: 427-35.
4. Knapp CC, Ludwig MD, Washington JA. In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion. Antimicrob Agents Chemother 1991; 35: 1230-1.
5. Midolo PD, Turnidge J, Lambert JR, Bell JM. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diag Microbiol Infect Dis 1995; 21: 135-40.
6. Glupzynski Y, Goutier S, Van den Borre C, Butzler JP, Burette A. Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994. Gut 1995: 37(Suppl. 1): A56.
7. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LR, Guerrant RL. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 1993, 31: 1971-4.
8. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29: 2072-5.
9. Metzler CM, DeHaan RM. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis 1974; 130: 588-94.
10. Hirschl AM, Hirschl MM, Rotter ME. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993; 32: 45-9.
11. National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters; Approved Guideline. NCCLS Document M23-A. Villanova, Pa: NCCLS, 1994
12. Midolo PD, Korman MG, Turnidge JD, Lambert JR. Helicobacter pylori resistance to tetracycline. Lancet 1996; 347: 1194-5.
13. Glupczynski Y. In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: Basis for treatment or microbiologists obsession. Int J Med Microbiol Virol Parisitol Infect Dis 1993; 280: 227-38.
14. Burette A, Glupczynski Y. Helicobacter pylori: The place of the new macrolides in the eradication of the bacteria in peptic ulcer disease. Infection 1995; 23 (Suppl. 1): S44-S52.
15. Cayla R, Zerbib F, Talibi P, Megraud F, Lamouliatte H. Pre and post treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995; 37 (Suppl. 1): A55.
16. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK et al. Mutations in 23S ribosomal RNA confer clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: 477-80.